Publikationen von Martin Gengenbacher

Zeitschriftenartikel (21)

2017
Zeitschriftenartikel
Zimmermann, M.; Kogadeeva, M.; Gengenbacher, M.; McEwen, G.; Mollenkopf, H.-J.; Zamboni, N.; Kaufmann, S. H. E.; Sauer, U.: Integration of Metabolomics and Transcriptomics Reveals a Complex Diet of Mycobacterium tuberculosis during Early Macrophage Infection. mSystems 2 (4), e00057-17 (2017)
Zeitschriftenartikel
Gengenbacher, M.; Duque-Correa, M. A.; Kaiser, P.; Schuerer, S.; Lazar, D.; Zedler, U.; Reece, S. T.; Nayyar, A.; Cole, S. T.; Makarov, V. et al.; Clifton, E. B. I.; Dartois, V.; Kaufmann, S. H. E.: NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans. Scientific Reports 7 (1), 8853 (2017)
Zeitschriftenartikel
Gengenbacher, M.; Nieuwenhuizen, N. E.; Kaufmann, S. H. E.: BCG — old workhorse, new skills. Current Opinion in Immunology 47, S. 8 - 16 (2017)
2016
Zeitschriftenartikel
Gengenbacher, M.; Nieuwenhuizen, N.; Vogelzang, A.; Liu, H.; Kaiser, P.; Schuerer, S.; Lazar, D.; Wagner, I.; Mollenkopf, H.-J.; Kaufmann, S. H. E.: Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis. mBio 7 (3), e00679-16 (2016)
Zeitschriftenartikel
Gengenbacher, M.; Kaiser, P.; Schuerer, S.; Lazar, D.; Kaufmann, S. H. E.: Post-exposure vaccination with the vaccine candidate Bacillus Calmette–Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis. Microbes and Infection 18 (5), S. 364 - 368 (2016)
2015
Zeitschriftenartikel
Schubert, O. T.; Ludwig, C.; Kogadeeva, M.; Zimmermann, M.; Rosenberger, G.; Gengenbacher, M.; Gillet, L. C.; Collins, B. C.; Röst, H. L.; Kaufmann, S. H. E. et al.; Sauer, U.; Aebersold, R.: Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis. Cell Host & Microbe 18 (1), S. 96 - 108 (2015)
Zeitschriftenartikel
Saiga, H.; Nieuwenhuizen, N.; Gengenbacher, M.; Koehler, A.-B.; Schuerer, S.; Moura-Alves, P.; Wagner, I.; Mollenkopf, H.-J.; Dorhoi, A.; Kaufmann, S. H. E.: The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation. The Journal of Infectious Diseases 211 (11), S. 1831 - 1841 (2015)
Zeitschriftenartikel
Rienksma, R. A.; Suarez-Diez, M.; Mollenkopf, H.-J.; Dolganov, G. M.; Dorhoi, A.; Schoolnik, G. K.; Santos, V. A. M. d.; Kaufmann, S. H. E.; Schaap, P. J.; Gengenbacher, M.: Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing. BMC Genomics 16 (1), 34 (2015)
2014
Zeitschriftenartikel
Vogelzang, A.; Perdomo, C.; Zedler, U.; Kuhlmann, S.; Hurwitz, R.; Gengenbacher, M.; Kaufmann, S. H. E.: Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis. The Journal of Infectious Diseases 210 (12), S. 1928 - 1937 (2014)
Zeitschriftenartikel
Gengenbacher, M.; Vogelzang, A.; Schuerer, S.; Lazar, D.; Kaiser, P.; Kaufmann, S. H. E.: Dietary Pyridoxine Controls Efficacy of Vitamin B6-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin ΔureC::hly Δpdx1 in Mice. mBio 5 (3), e01262-14 (2014)
Zeitschriftenartikel
Kaufmann, S. H. E.; Cotton, M. F.; Eisele, B.; Gengenbacher, M.; Grode, L.; Hesseling, A. C.; Walzl, G.: The BCG replacement vaccine VPM1002: from drawing board to clinical trial. Expert Review of Vaccines 13 (5), S. 619 - 630 (2014)
Zeitschriftenartikel
Gengenbacher, M.; Mouritsen, J.; Schubert, O. T.; Aebersold, R.; Kaufmann, S. H. E.: Mycobacterium tuberculosis in the Proteomics Era. Microbiology Spectrum 2 (2), MGM2-0020-2013 (2014)
2013
Zeitschriftenartikel
Rao, M.; Vogelzang, A.; Kaiser, P.; Schuerer, S.; Kaufmann, S. H. E.; Gengenbacher, M.: The Tuberculosis Vaccine Candidate Bacillus Calmette-Guérin ΔureC::hly Coexpressing Human Interleukin-7 or -18 Enhances Antigen-Specific T Cell Responses in Mice. PLoS One 8 (11), e78966 (2013)
Zeitschriftenartikel
Sparr, C.; Purkayastha, N.; Kolesinska, B.; Gengenbacher, M.; Amulic, B.; Matuschewski, K.; Seebach, D.; Kamena, F.: Improved Efficacy of Fosmidomycin against Plasmodium and Mycobacterium Species by Combination with the Cell-Penetrating Peptide Octaarginine. Antimicrobial Agents and Chemotherapy 57 (10), S. 4689 - 4698 (2013)
Zeitschriftenartikel
Schubert, O. T.; Mouritsen, J.; Ludwig, C.; Röst, H. L.; Rosenberger, G.; Arthur, P. K.; Claassen, M.; Campbell, D. S.; Sun, Z.; Farrah, T. et al.; Gengenbacher, M.; Maiolica, A.; Kaufmann, S. H. E.; Moritz, R. L.; Aebersold, R.: The Mtb Proteome Library: A Resource of Assays to Quantify the Complete Proteome of Mycobacterium tuberculosis. Cell Host & Microbe 13 (5), S. 602 - 612 (2013)
Zeitschriftenartikel
Velmurugan, K.; Grode, L.; Chang, R.; Fitzpatrick, M.; Laddy, D.; Hokey, D.; Derrick, S.; Morris, S.; McCown, D.; Kidd, R. et al.; Gengenbacher, M.; Eisele, B.; Kaufmann, S. H. E.; Fulkerson, J.; Brennan, M. J.: Nonclinical Development of BCG Replacement Vaccine Candidates. Vaccines 1 (2), S. 120 - 138 (2013)
Zeitschriftenartikel
Sarathy, J.; Dartois, V.; Dick, T.; Gengenbacher, M.: Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 57 (4), S. 1648 - 1653 (2013)
2012
Zeitschriftenartikel
Kaufmann, S. H. E.; Gengenbacher, M.: Recombinant live vaccine candidates against tuberculosis. Current Opinion in Biotechnology 23 (6), S. 900 - 907 (2012)
Zeitschriftenartikel
Gengenbacher, M.; Kaufmann, S. H. E.: Mycobacterium tuberculosis: success through dormancy. FEMS MICROBIOLOGY REVIEWS 36 (3 Sp. Iss. SI), S. 514 - 532 (2012)
Zeitschriftenartikel
Warrier, T.; Tropis, M.; Werngren, J.; Diehl, A.; Gengenbacher, M.; Schlegel, B.; Schade, M.; Oschkinat, H.; Daffe, M.; Hoffner, S. et al.; Eddine, A. N.; Kaufmann, S. H. E.: Antigen 85C Inhibition Restricts Mycobacterium tuberculosis Growth through Disruption of Cord Factor Biosynthesis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 56 (4), S. 1735 - 1743 (2012)
Zur Redakteursansicht